-
DE
Milk Basic Protein (MBP) is a bioactive whey protein fraction derived from cow's milk, studied for its role in supporting bone health and increasing bone mineral density.
Add as Preferred SourceMilk Basic Protein (MBP) is a bioactive whey protein fraction derived from cow's milk, studied for its role in supporting bone health and increasing bone mineral density.
Milk Basic Protein (MBP) is a specific cationic protein fraction found in small amounts in the whey of cow's milk. MBP accounts for only about 0.03 % of total whey protein and is isolated through specialized separation processes. It consists of a group of basic proteins including lactoperoxidase, lactoferrin, and other cationic proteins. In research and as a dietary supplement, MBP is primarily studied and used for its potential effects on bone metabolism.
MBP influences bone metabolism through two key mechanisms:
This dual effect on bone remodeling makes MBP a compelling bioactive compound in the field of bone health. Laboratory studies have demonstrated that MBP stimulates osteoblast differentiation and proliferation while reducing bone resorption by osteoclasts.
MBP is primarily applied or investigated in the following areas:
Clinical studies have typically used doses of 40 mg of MBP per day. Since MBP is present in milk and whey in very small concentrations, obtaining therapeutically relevant amounts through a normal diet is not feasible. Therefore, MBP is predominantly consumed as a concentrated extract in supplement form. Intake should ideally be discussed with a physician or registered dietitian.
MBP occurs naturally in cow's milk and whey, but only in very small quantities. Processed dairy products such as cheese, yogurt, or butter generally do not contain relevant amounts of intact MBP, as the protein may be partially denatured or degraded during processing.
MBP is considered safe and well-tolerated at the doses used in studies (up to 40 mg/day). However, individuals with a cow's milk protein allergy or lactose intolerance should exercise caution and consult a healthcare professional before use. Long-term data on potential side effects at higher doses remain limited.
Most clinical studies on MBP originate from Japan and were conducted with relatively small study populations. The results are promising; however, further independent large-scale studies are needed to fully establish the efficacy and safety of MBP. MBP is not a substitute for a balanced, calcium-rich diet and a healthy lifestyle in supporting bone health.